ECRI examines health technologies' future:
This article was originally published in Clinica
ECRI's latest Health Technology Forecast examines a broad spectrum of technology developments. The forecast analyses such topics as the validity of new techniques in minimally invasive surgery, advances in breast cancer detection, the development of small-bore MRI systems, the impact insulin pump therapy has on metabolic control of insulin-dependent diabetes and the prophylactic use of automatic implantable defibrillators. Health Technology Forecast is available for $195 from ECRI's circulation department at 5200 Butler Pike, Plymouth Meeting, PA 19462-1298, US. Tel: +1 (610) 825-6000. Fax: +1 (610) 834-1275. e-mail: firstname.lastname@example.org.
You may also be interested in...
Unilever North America agrees SmartyPant, founded in 2011 to create a comprehensive supplement made from premium ingredients to support the wellbeing needs of children and adults. Kind, fully owned by Mars, has an agreement to acquire family-owned Nature's Bakery which offers snacks including fig bars and other soft-baked foods.
Arcadia prohibited from arguing against Advantice’s appeal of National Advertising Division decision that Kerasal Fungal Nail Renewal ad claims weren’t supported. Arcadia violated confidentiality rule by publicizing NAD decision before the review was officially closed.
The C-suite leaders schemed to falsely record shipments of unwanted products to distributors as sales so the company could meet revenue projections, the government charged.